OmniAb Inc

NASDAQ:OABI  
4.17
-0.17 (-3.92%)
7:17:00 PM EDT: $4.25 +0.08 (+1.92%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)460.03M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$25.72 Million
Adjusted EPS$0.02
See more estimates
10-Day MA$4.19
50-Day MA$3.67
200-Day MAN/A
See more pivots

OmniAb Inc Stock, NASDAQ:OABI

5980 Horton Street, Suite 600, Emeryville, California 94608
United States of America
Phone: +1.510.250.7800
Number of Employees:

Description

OmniAb, Inc. operates as a drug discovery company. It focuses on developing human monoclonal and bispecific therapeutic antibodies. The firmâ??s platform includes the biological intelligence of its transgenic animals, including OmniRat, OmniChicken and OmniMouse. The company was founded on December 14, 2015 and is headquartered in Emeryville, CA.